Pediatrix Medical Group MD Share Repurchase Program, Authorized, Amount

Share Repurchase Program, Authorized, Amount at other companies

AmetekAME

$1.25B—

Apollo Global ManagementAPO

$4B—

L3Harris TechnologiesLHX

$3B—

Carrier GlobalCARR

$12.1B—

Williams CompaniesWMB

$1.5B—

eBayEBAY

$5B—

Other financials

Income statement

See full

Revenue$476.2M+3.9%

Operating income$41.7M+29.8%

Net income$29.6M+42.6%

EPS (diluted)$0.36+50.0%

Balance sheet

See full

Cash & equivalents$205.8M+108%

Total debt$629.7M-3.9%

Total equity$878.6M+11.3%

Total assets$2.1B+3.9%

Cash flow

See full

Operating cash flow-$129.8M-10.5%

CapEx$6.2M+88.3%

Free cash flow-$136.1M-12.7%

Valuation

See full

Market cap$1.99B+42.9%

Enterprise value$2.41B+22.3%

P/E11.4×—

P/S1×+0.3×

Profitability

See full

Operating margin11.3%—

Net margin9%—

FCF margin12.3%+2.5pp

Returns & leverage

See full

Return on equity20.9%—

Debt / equity0.7×-0.1×

Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept srt:StockRepurchaseProgramAuthorizedAmount1.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's share repurchase program, authorized, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pediatrix Medical Group's share repurchase program, authorized, amount?: Pediatrix Medical Group (MD) reported share repurchase program, authorized, amount of $250M in Q3 2025.